Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Oct;4(5):855-64.
doi: 10.2147/ndt.s3739.

Brain ischemia and ischemic blood-brain barrier as etiological factors in sporadic Alzheimer's disease

Affiliations

Brain ischemia and ischemic blood-brain barrier as etiological factors in sporadic Alzheimer's disease

Ryszard Pluta et al. Neuropsychiatr Dis Treat. 2008 Oct.

Abstract

The development of neuronal death and amyloid plaques is a characteristic feature of ischemic- and Alzheimer-type dementia. An important aspect of neuronal loss and amyloid plaques are their topography and neuropathogenesis. This review was performed to present the hypothesis that different fragments of blood-borne amyloid precursor protein are able to enter the ischemic blood-brain barrier. Chronic disruption of the blood-brain barrier after ischemic injury was shown. As an effect of chronic ischemic blood-brain barrier injury, a visible connection of amyloid plaques with neurovasculature was observed. This neuropathology appears to have similar distribution and mechanisms to Alzheimer's disease. The usefulness of rival ischemic theory in elucidating the neuropathogenesis of amyloid plaques formation and neuronal death in Alzheimer's disorder is discussed.

Keywords: Alzheimer’s disease; amyloid plaques; brain ischemia; dementia; ischemic blood-brain barrier; leukocytes; neuronal death; platelets.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic diagram of the main ischemic pathological processes in sporadic Alzheimer’s disease. Abbreviations: APP, amyloid precursor protein; βA, β-amyloid peptide; BBB, blood–brain barrier.
Figure 2
Figure 2
Role of estrogen in ischemic β-amyloid peptide neuropathology and ischemic brain cells injury. Abbreviation: BBB, blood–brain barrier.

Similar articles

Cited by

References

    1. Abramov AY, Canevari L, Duchen MR. Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J Neurosci. 2003;23:5088–95. - PMC - PubMed
    1. Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatr Psych Gericht Med (Berlin) 1907;64:146–8.
    1. Anfuso CD, Assero G, Lupo G, et al. Amyloid beta (1–42) and its beta (25–35) fragment induce activation and membrane translocation of cytosolic phospholipase A (2) in bovine retina capillary pericytes. Biochem Biophys Acta. 2004;1686:125–38. - PubMed
    1. Arshavsky YL. Alzheimer’s disease, brain immune privilege and memory: A hypothesis. J Neural Transm. 2006;113:1697–707. - PubMed
    1. Attems J, Jellinger KA. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology – a pilot study. Acta Neuropathol. 2004;107:83–90. - PubMed